A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function

Trial Profile

A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2018

At a glance

  • Drugs Atrasentan (Primary)
  • Indications Diabetic nephropathies
  • Focus Pharmacodynamics
  • Sponsors AbbVie
  • Most Recent Events

    • 25 May 2018 Planned End Date changed from 30 May 2019 to 18 Apr 2019.
    • 13 Feb 2018 Planned primary completion date changed from 12 Dec 2017 to 19 Apr 2018.
    • 01 Feb 2018 This trial has been completed in Spain.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top